Detalles de la búsqueda
1.
Comparative effectiveness of tofacitinib and tumour necrosis factor inhibitors in patients with rheumatoid arthritis in real-world practice: a prospective observational study.
Rheumatology (Oxford)
; 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38366621
2.
Safety and effectiveness of tofacitinib in Korean adult patients with rheumatoid arthritis: A post-marketing surveillance study.
Mod Rheumatol
; 33(6): 1087-1096, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36401881
3.
The risk factors and incidence of major infectious diseases in patients with ankylosing spondylitis receiving tumor necrosis factor inhibitors.
Mod Rheumatol
; 31(6): 1192-1201, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33494621
4.
A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis.
BMC Dermatol
; 16(1): 11, 2016 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27455955
5.
Comparisons of treatment satisfaction and health-related quality of life in patients with rheumatoid arthritis treated with tofacitinib and adalimumab.
Arthritis Res Ther
; 25(1): 68, 2023 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37106411
6.
Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study.
Sci Rep
; 13(1): 7877, 2023 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37188765
7.
Real-world treatment patterns for atopic dermatitis in South Korea.
Sci Rep
; 12(1): 13626, 2022 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35948589
8.
Treatment pattern, satisfaction, and productivity loss of patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors in Korea: A multicenter cross-sectional observational study.
Int J Rheum Dis
; 25(5): 523-531, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35187866
9.
Real-World Incidence of Suboptimal Response to Anti-Tumor Necrosis Factor Therapy for Ulcerative Colitis: A Nationwide Population-Based Study.
Gut Liver
; 15(6): 867-877, 2021 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33785664
10.
Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South Korea.
Rheumatol Ther
; 8(1): 395-409, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33496958
11.
Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing Spondylitis.
Rheumatol Ther
; 8(1): 347-359, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33420967
12.
Difference of body compositional changes according to the presence of weight cycling in a community-based weight control program.
J Korean Med Sci
; 25(1): 49-53, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20052347
13.
Cep215 is essential for morphological differentiation of astrocytes.
Sci Rep
; 10(1): 17000, 2020 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33046744
14.
HDAC3 and HDAC8 are required for cilia assembly and elongation.
Biol Open
; 8(8)2019 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31362948
15.
Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia-Pacific region: Post-hoc analyses of pooled clinical study data.
Int J Rheum Dis
; 22(6): 1094-1106, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30900375
16.
Hospital Utilization and Medication Prescriptions among Patients with Atopic Dermatitis in South Korea: A Real-World Data Analysis.
Ann Dermatol
; 35(5): 374-388, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37830420
Resultados
1 -
16
de 16
1
Próxima >
>>